Key takeaways:
- Eligible claimants could receive $10,000 to $165,000 under the settlement.
- Bayer faced approximately 65,000 Roundup claims in U.S. state and federal courts, according to The Guardian.
- Bayer denies Roundup causes cancer; the WHO’s cancer agency and the EPA have reached differing conclusions about glyphosate’s cancer risk.
A Missouri judge has approved a nationwide settlement that could cost Bayer up to $7.25 billion to resolve lawsuits alleging its Roundup weedkiller caused cancer, clearing a path for payments to thousands of people with non-Hodgkin lymphoma.
Judge Timothy Boyer of a state court in St. Louis gave final approval Friday, finding the agreement “fair, reasonable and adequate.” The settlement covers people who have been diagnosed with the blood cancer as well as those who may be diagnosed in the future and claim it is linked to glyphosate, Roundup’s main ingredient.
Individual payments could range from $10,000 to $165,000, NPR reported. The amounts depend on factors including a claimant’s age at diagnosis and whether agricultural or other work exposed them to higher levels of glyphosate.
Boyer overruled objections that the payments were too low compared with earlier Roundup settlements, The Guardian reported. Delaying compensation, he said, could leave victims — including people with terminal cancer — waiting “an indeterminate number of years” for payment. NPR reported that Boyer called the deal “among the largest in the history of mass tort personal-injury class action settlements.”
Bayer faced approximately 65,000 Roundup claims in U.S. state and federal courts, according to The Guardian. The settlement, announced in February, was designed to resolve nearly all current and future U.S. claims. It does not cover some lawsuits still pending in federal court; Bayer has said about 200 of those cases remain in litigation.
“The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” Bayer CEO Bill Anderson said in a statement.
Christopher Seeger, a lawyer for the plaintiffs, said the approval “delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.” He said he wanted to get the payments to victims as quickly as possible.
The ruling follows a U.S. Supreme Court decision in Bayer’s favor. In a 7-2 vote, the court overturned a $1.25 million jury award to a Missouri man who attributed his non-Hodgkin lymphoma to years of Roundup exposure. The justices agreed that federal pesticide law barred claims under state law that Bayer had failed to warn consumers, a decision Seeger said narrowed victims’ ability to pursue such cases in court.
Bayer, which bought Roundup maker Monsanto for $63 billion in 2018, has long denied that Roundup or glyphosate causes cancer. The company previously agreed to pay roughly $10 billion to $11 billion to settle more than 100,000 Roundup claims, according to NPR; The Guardian reported that a proposed $1.25 billion deal for future claims failed to win court approval.
The World Health Organization’s cancer agency concluded more than a decade ago that glyphosate is probably carcinogenic to humans. The U.S. Environmental Protection Agency, by contrast, has said it “did not identify risks of concern from glyphosate uses, including for cancer,” though NPR reported that it is reviewing evidence on human health. Bayer removed glyphosate from its U.S. residential products several years ago, NPR reported, but it remains in agricultural use.
Be First to Comment